INTRODUCTION
The home enteral nutrition (HEN) is a form of delivering nutritional support for children with chronic diseases who are nutritionally compromised. The initiation of HEN allows children to be discharged earlier from hospitals, and significantly improves the quality of life for patients by increasing independence in familiar surroundings. In the past, HEN was only provided to patients with advanced disease. Currently, because of the improved understanding of this technique, the existence of multidisciplinary teams, the availability of materials adapted for children and portable equipment that is simple to use, as well as the recent legislation in Spain (Royal Decree 1030/2006; Order SCO/3858/ 2006; Royal Decree 1205/2010), the approach to HEN in these patients has substantially changed. As a result, HEN is initiated earlier, which allows for a better prognosis and quality of life for patients and their families. Furthermore, early initiation of HEN 1 decreases the incidence of complications and cost related to prolonged hospital stays. 1, 2 The health records comprise information systems that document the geographical and temporal distribution of diseases or studied events. These systems also assist the healthcare team in planning for ordering and allocating resources for patients, conducting clinical research and evaluating applied technologies. Until a few years ago, precise data on the use of HEN in Spanish children did not exist. For this reason, in 2003, the Spanish Society for Pediatric Gastroenterology, Hepatology and Nutrition (SEGHNP) helped to create the NEPAD registry (Nutrició n Enteral Pediátrica Ambulatoria y Domiciliaria, Pediatric Ambulatory and Home Enteral Nutrition). The goals for establishing this patient registry included gathering information on indications, modes of administration, types of diet and duration of nutrition support. A recent systematic review of artificial nutrition registries revealed few published studies based on this type of data. 3 At present, the active HEN registries worldwide include BAPEN (BANS) 4 in the UK, the NSW HEN Register in Australia and NADYA-SENPE 5, 6 and NEPAD, which are both Spanish (Supplementary Table 1 ).
Since 2000, the British registry, BANS, has included 700-1000 children annually. Over the past 3 years, however, the need for obtaining informed consent has led to a decrease in patient enrollment, which is in the process of being remedied. 4 Since 1992, the NADYA 5, 6 registry has been in place in Spain and primarily gathers adult data. The NADYA registry only registers the data from a small percentage (5%) of pediatric patients up to the age of 14 years. To the best of our knowledge, the NEPAD registry is the only registry in the world with exclusively pediatric data. The aim of our study was to report the implementation of the NEPAD registry of pediatric HEN in Spain and to analyze data evolution trends from 2003 to 2010. We evaluated the following variables: the primary diagnosis of patients, age at initiation, indications for HEN, route of HEN administration used, types of enteral feed, infusion regimen, duration of the support and reason for HEN discontinuation.
PATIENTS AND METHODS

Design of the NEPAD registry
The NEPAD registry is a web-based registry of pediatric patients who require or previously required HEN. Medical professionals who work in the national hospitals and care for these patients voluntarily enter the data. The NEPAD registry is accessed through the Spanish Society for Pediatric Gastroenterology, Hepatology and Nutrition website www.gastroinf.com. Professionals must enter a unique code to access the registry and may only review and modify the data corresponding to their own centre. Confidentiality of the data is guaranteed according to the Protection of Personal Data Law 15/99 (BOE 298, of 14-Dec-1999 , (e) adult polymeric formula (all nutritionally complete formulas with whole proteins adequate for children older than 10 years and adults) and (f) other formulas, including special-design formulas (for example, for renal and hepatic disease) and incomplete formulas, such as glucose polymers or protein powders. In the case of a patient requiring more than one type of enteral formula, the one that was more frequently administered was used for data analysis. (7) The route of HEN administration in each episode (initial and final) was classified into four categories: (a) oral (only when the patients received at least 50% of their daily energy requirements with a formula and orally), 7 (b) nasogastric tube (NGT), (c) gastrostomy (G) and (d) jejunal access (JA). Children could be partially or totally fed through a tube. The patients may have more than one episode, which was defined as the time at which they were receiving HEN support.
We excluded patients whose treatment was strictly dietary and orally based, such as patients treated with a hydrolysed formula owing to cow's milk protein allergy or patients who consumed specific products because of their metabolic disease.
The initiation date of HEN was documented as the time at which the patient was discharged from the hospital, even if initiation of nutritional support occurred before this time.
The registry includes an online manual containing detailed explanations of data entry, modification processes and the termination of episodes. The manual also includes an appendix describing the formulas available on the Spanish market and the classification to which they belong.
Statistical analysis
A descriptive analysis was carried out first. The quantitative variables following a normal distribution were expressed with the mean and s.d., whereas those not following a normal distribution were described with the median and interquartile range (IQR). Qualitative variables were described using frequencies and percentages. The Kolmogorov-Smirnov test was used to evaluate whether the sample followed a normal distribution. When the sample did not follow a normal distribution, the following nonparametric tests were used: Pearson's w 2 test, the Mann-Whitney U test for two independent samples and the Kruskal-Wallis test for several independent samples. We considered Po0.05 to be statistically significant.
RESULTS
General characteristics of the patients
We analysed data from 952 patients from 20 Spanish hospitals, consisting of a total of 1048 episodes, during the period September 2003-October 2010. Of the total study population, 51% were male (n ¼ 488). The median age at initiation of HEN was 1.6 years (IQR, 0.6-6.1 years) and 37% were younger than 12 months (Supplementary Figure 1) .
As initiation of the NEPAD registry, the number of patients included each year has increased more than 25-fold. The mean number of patients enrolled during the study was 107 patients/ year ( Figure 1 ). A total of 22 patients (2.3%) received home parenteral nutrition simultaneously with HEN, and 60% of these patients suffered from short-bowel syndrome.
Indications and initiation of HEN The categories of principal diagnosis and the most frequent disease subtypes are shown in Table 1 . The age of commencing nutritional support was significantly affected by the diagnosis of the patient (Kruskal-Wallis test, Po0.0001; Figure 2 ). The patients with swallowing disorders that were neither neurological nor digestive initiated HEN at the youngest age, with a median age of 0.4 years (IQR, 0.2-1.3 years). Patients with neurological disorders initiated HEN at the oldest age, with a median age of 2.8 years (IQR, 0.8-8.9 years). The indications for the initiation of nutritional support were the decreased oral intake in 64% of the cases, inability to compensate for the increased metabolic needs related to an underlying disease in 24% of the cases and as a result of alterations in digestion and/or metabolism in the remaining 12%.
Route of HEN administration
The nutritional support was delivered through NGT in 573 episodes (54.7%), by G in 375 episodes (35.8%), orally in 77 episodes (7.3%) and by JA in 23 episodes (2.2%). The route of administration was significantly affected by the child's disease (w 2 , Po0.0001). Out of a total of 1048 episodes, 10.2% (107 episodes, 96 patients) underwent a change from the initial access route over the following 3.7 months (IQR, 1.6-8.7 months). After the changes, the nutrition was delivered through NGT in 476 episodes (45.6%), G in 471 episodes (44.9%), orally in 82 episodes (7.7%) and JA in 19 episodes (1.8%) (Figure 3) . A total of 17% of patients suffering from metabolic diseases, 17% with neurological diseases and 13% with swallowing disorders changed their initial feeding route, compared with the 8% of patients with cardiorespiratory diseases, 3% with digestive diseases and 2% with oncologic diseases (w 2 , Po0.0001).
Variables related to the nutritional support Of the 876 patients (971 episodes) who were tube-fed, 75.5% (n ¼ 662, 741 episodes) consumed enteral formula, 19% (n ¼ 167, 179 episodes) consumed mixed food (enteral formula and homemade foods) and 5.3% (n ¼ 47, 51 episodes) were exclusively fed with homemade foods. The type of food used varied significantly (w 2 , Po0.0001) according to the final route of administration (Supplementary Figure 2) . A feeding pump was used in 80.5% of the episodes in which nutrition was administered via a tube (696 patients, 782 episodes). In this group, the most frequent infusion regimen was the cyclic regimen (372, 47.6%), followed by mixed (245, 31.3%), continuous (89, 11.4%) and bolus-intermittent (76, 9.7%). For episodes in which no feeding pump was used, the most frequent type of infusion was bolusintermittent (185, 98%), followed by mixed (4, 2%).
Considering cases using enteral formula delivered through the tube (920 episodes, 829 children), the most frequently used were Registry of home enteral nutrition in children C Pedró n-Giner et al pediatric polymeric formula (51.7%, 476 episodes), followed by special formula for infants (18.2%, 167) and formula for healthy infants (10.3%, 95). In the patients fed orally (94 episodes, 93 children), the most frequently used formula was pediatric polymeric formula (41.4%, 39), followed by an adult polymeric formula (28.7%, 27) . In all, 92% of the patients fed orally with an adult polymeric formula were suffering from inflammatory bowel disease. The Figure 4 shows the type of formula administered, which varied significantly based on underlying disease (w 2 , Po0.0001) and was not related to access route. At the time of data analysis, a total of 735 episodes out of 676 registered patients (70.5%) had concluded nutritional support. This discontinuation was due to progression to oral intake in 64.8%, inability to reach the expected objectives in 9.7%, transfer to a different centre in 9.1%, hospitalisation in 5.2% and death in 11.2% of the patients (60% of these were patients with neurological diseases and 15% were patients with oncologic diseases).
The median duration of nutritional support in patients who had completed the HEN support at the time of data analysis was 4 months (IQR 1.3-15.2 months). There were significant differences (Kruskal-Wallis test, Po0.0001) in the duration of nutritional support based on both underlying disease and enteral access route ( Figure 5 ). Remarkably, we observed that when a support through a G was indicated, the duration of nutritional support was not influenced by the patient's disease (Kruskal-Wallis test, P ¼ 0.132). In contrast, when nutritional support was delivered trough an NGT, the duration was influenced by patient disease (Kruskal-Wallis test, Po0.0001), being longest in patients suffering from cardiorespiratory diseases. The median age of patients at the time of HEN discontinuation was 2. 
DISCUSSION
The NEPAD registry, which was established in 2003, 8 is a growing registry that offers a range of data on pediatric HEN in Spain. The available data from this series were collected from 20 Spanish hospitals. Other publications may report on a series with a significant number of patients [9] [10] [11] [12] [13] but only from one centre, with the exclusion of a recent publication that gathered data from a national survey. 14 To our knowledge, the NEPAD registry is the only registry around the world that gathers exclusively pediatric data.
Precise knowledge on the timing of HEN is associated with a range of limitations. [15] [16] [17] The first limitation is related to the concept and indication of HEN. Our registry included all patients receiving tube feedings and those who orally consumed more than 50% of their daily energy requirements through a defined chemical diet. 7 The second limitation is the type of existing guidelines for the use of HEN in each country that regulates clinical practice. [18] [19] [20] The third is the method of documenting clinical care through the registries 21 and the need for professionals to be both educated about and aware of the importance of complying with registry regulations. It is important to consider that the registries are voluntary; in addition, they constitute additional work for the professionals staffing the nutrition units. Currently, in our health system, we do not have information systems that can send patient data directly to the registries. The fact that the NEPAD is a voluntary registry promotes a considerable bias when attempting to understand the real number of HEN cases in Spain. The Figure 1 shows the prospective introduction of patients into the registry and illustrates the growing number of recruited patients and participating hospitals; however, at present, these data do not allow us to calculate the incidence nor the prevalence of HEN. The increase in participation in the registry has been due to promotional campaigns in national and international meetings, information available on the Spanish Society for Pediatric Gastroenterology, Hepatology and Nutrition website and periodic Internet reminders to update data among other causes.
With regard to the variables analysed, the age at initiation of nutritional support was similar to that reported by Salomon et al. 9 and was lower compared with that reported by Daveluy et al. 22 This difference could be an indication of the complexity of our patients and also the intent to improve patient prognosis by implementing earlier treatment. The BANS 4 registry highlights the fact that the percentage of children younger than 1 year has progressively increased, rising from 22.1% in 2000 to 40.6% in 2010. In our registry, children younger than 12 months accounted for 37% of the cases.
With regard to the principal diagnosis of patients with HEN, the most frequent disease category was neurological, followed by gastrointestinal, oncologic and cardiorespiratory diseases, as described in other studies. 6, [10] [11] [12] 14, 22, 23 The indication for HEN varies among studies as a function of hospital characteristics and the complexity profile of the patients. In our study, children with non-neurological and non-digestive swallowing disorders initiated HEN at the youngest age, and patients who initiated HEN at the oldest age were those with neurological diseases whose condition worsened over time. Patients with congenital heart diseases initiated HEN early and discontinued support at very similar ages, as many no longer required enteral support following surgical intervention. In contrast, patients with cystic fibrosis can require enteral support at varying ages.
With respect to the type of enteral access route, we found that the patients from the NEPAD registry were primarily fed by tube. Only 7.3% of patients used the oral route for initiation of HEN, which prevents the bias associated with the administration of a defined composition formula as a supplement that is a frequent occurrence in the adult registry in our country. 5 The NGT route was most frequently used, similar to that reported by the other pediatric studies, 4, 9, 10, 12, 13, 22 and in many cases the NGT was used as a transitional access route to gastrostomy, as was evident in our patient population. Of the 96 patients who changed delivering routes, 88 had an NGT and 85 changed to a G in a very short period of time, most likely as a result of improvement in their nutritional status and goals of decreasing postsurgical complications and complications secondary to malnutrition. 24 In our series, G was indicated more frequently in children with neurological diseases, with more than 70% of patients having a G, given that in the majority of cases their underlying condition was difficult to reverse ( Figure 3 ). The application of new endoscopic techniques allows us to decrease the intervention time and facilitates the use of G in this specific group of patients. [25] [26] [27] [28] The JA, which is primarily used in the case of severe gastroesophageal reflux or uncontrolled gastroparesis, is unusual in children, 29 as was true in our series.
The use of feeding pumps is a frequent practice for children, as it allows for controlled and safe administration of enteral formula. 11 In our patient series, the use of a pump (80.5%) corresponded with those episodes using infusion types that were continuous, cyclic or mixed.
The indication of one specific type of enteral formula should be individualised based on age, nutritional status, underlying disease and gastrointestinal function. Most patients in this study maintained normal gastrointestinal function, did not have special energy or nutrient requirements and consumed complete formulas appropriate for their age. Pediatric polymeric formula was the most commonly used formula, as it is indicated for a wide range of ages. The special formulas, either for infants or for different inborn errors of metabolism, were used in the case of gastrointestinal diseases, where organ dysfunction or metabolic alterations were present. 9, 12, 13 In our country, homemade food is commonly delivered through G in many children who require intensive nutritional support. 30 This type of support is often preferred by parents/caregivers who consider that homemade food is more nutritionally complete than formula food. Furthermore, preparing homemade food that may be adapted for tube administration often has a positive effect on parents, as they feel that they are contributing to the adequate nourishment of their children. In our series, 5.3% of patients requiring tube feeding consumed exclusively homemade food and 19% consumed a combination of homemade food and formula food. The majority of patients who used this type of combination feeding had neurological diseases.
The duration of the nutritional support depended on the disease and the access route. In general, the duration of support with NGT is shorter, although it may be prolonged in certain pathologies that include self-limiting processes. For example, for pediatric diseases that have a definitive solution in the moderate short term, such as with congenital heart diseases that require surgical intervention, nutritional support lasts for several months but is usually not required postoperatively. Alternatively, support is often indefinite in patients with a G, independent of the diagnosis and age at initiation of HEN.
The limitations of this study are primarily related to the fact that the introduction of patients and clinical changes are not made in parallel to clinical follow-up. In general, they are performed at a later time and there is a lack of participation of many hospitals in the country because of the voluntary nature of the registry. For this reason, until now, we have been unable to establish the yearly incidence of HEN or changes in daily practice. To increase the data homogeneity, we reduced the variables included in the registry; the data regarding complications were not recorded.
In conclusion, multicentre HEN registries such as NEPAD provide us with extremely valuable information on the practice of this type of nutritional support, which can help improve and deepen our understanding of specific aspects or concrete pathologies related to HEN. Many children with chronic diseases benefit from HEN; those with neurological disease constitute the population that most commonly uses HEN. The cyclic infusion is the most frequent administration method, likely because it allows for greater autonomy of the children and their families. The majority of patients used pumps and polymeric formula, and transition to oral feeding was the main reason for discontinuation of HEN support.
